Cell Biology Laboratory, Department of Biochemistry, University of Madras, Chennai, India.
Basic Clin Pharmacol Toxicol. 2018 Aug;123(2):122-129. doi: 10.1111/bcpt.12975. Epub 2018 May 28.
The respiratory disease pulmonary fibrosis (PF), which is characterized by scar formation throughout the lung, imposes a serious health burden. No effective drug without side effects has been proven to prevent this fatal lung disease. In this context, this study was undertaken to elucidate the protective effect of celastrol, a quinine methide pentacyclic triterpenoid from a Chinese medicinal plant 'thunder god vine' against bleomycin (BLM)-induced PF. We also attempted to study how the cytokine transforming growth factor-β (TGF-β) stimulates fibrosis through the induction of epithelial-mesenchymal transition (EMT) and the role of celastrol in regulating EMT. TGF-β (5 ng/ml) was administered to human alveolar epithelial adenocarcinoma A549 cells to induce fibrotic response in cells. Induction of EMT was analysed in cells through morphological analysis and expression of epithelial and mesenchymal markers by Western blotting. Bleomycin at a concentration of 3 U/Kg b.w was used to induce fibrosis in adult male rat lungs. Celastrol (5 mg/kg b.w) was given to rats twice a week after BLM administration for a period of 28 days. Western blot and immunofluorescence analyses were performed with lung tissue sample to find out the potential of celastrol in regulating EMT during the progression of fibrosis. TGF-β induces EMT in A549 cells as demonstrated by changes in epithelial cell morphology and expression of epithelial and mesenchymal marker proteins. The expressions of epithelial marker proteins E-cadherin and claudin were found to be reduced in the BLM-induced group of rats. Expression of mesenchymal markers, such as N-cadherin, snail, slug, vimentin and β-catenin, was enhanced in BLM-induced rat lungs. Celastrol reverts these cellular changes in rat lungs, and it was found that celastrol regulates EMT through the inhibition of heat shock protein 90 (HSP 90). Together, the results indicate that EMT is a crucial phenomenon for the progression of fibrosis, and celastrol provides protection against PF through the regulation of EMT.
肺部疾病肺纤维化(PF)的特征是肺部广泛形成疤痕,对健康造成严重负担。目前尚无有效且无副作用的药物可预防这种致命的肺部疾病。在这种情况下,进行了这项研究,以阐明从中药“雷公藤”中提取的藜芦碱(celastrol)对博莱霉素(BLM)诱导的 PF 的保护作用。我们还试图研究细胞因子转化生长因子-β(TGF-β)如何通过诱导上皮-间充质转化(EMT)刺激纤维化,以及 celastrol 在调节 EMT 中的作用。用 5ng/ml TGF-β处理人肺泡上皮腺癌 A549 细胞,以诱导细胞发生纤维反应。通过细胞形态分析和 Western blot 检测上皮和间充质标志物的表达,分析 EMT 的诱导。用 3U/Kg bw 的博莱霉素诱导成年雄性大鼠肺部纤维化。在 BLM 给药后,每周两次给予 celastrol(5mg/kg bw),持续 28 天。用 Western blot 和免疫荧光分析肺组织样本,以发现 celastrol 在纤维化进展过程中调节 EMT 的潜力。TGF-β诱导 A549 细胞发生 EMT,表现为上皮细胞形态的变化和上皮和间充质标志物蛋白的表达。在 BLM 诱导的大鼠组中,发现上皮标志物蛋白 E-钙粘蛋白和闭合蛋白的表达减少。间充质标志物蛋白,如 N-钙粘蛋白、snail、slug、波形蛋白和β-连环蛋白的表达在 BLM 诱导的大鼠肺部增强。Celastrol 逆转了大鼠肺部的这些细胞变化,并且发现 celastrol 通过抑制热休克蛋白 90(HSP 90)来调节 EMT。总之,这些结果表明 EMT 是纤维化进展的关键现象,celastrol 通过调节 EMT 为 PF 提供保护。